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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S143became detectable, while Col10a1 mRNA was strongly increased, but to
a lesser extent in COG5-. Alizarin red was stronger in controls.
Conclusions: COG5 defect reduces the chondrogenesis process, despite
active BMP-Smad signaling. As COG5 also affected the expression and
glycosylation pattern of speciﬁcWnts, this underlines its critical role in the
fate of chondrogenic cells, and may point to a role in OA.
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SNORC, A NEW SPECIFIC MARKER OF HUMAN DIFFERENTIATED
ARTICULAR CHONDROCYTES
D. Ollitrault, Jr., F. Legendre, Jr., T. Gomez-Leduc, Jr., N. Bigot, Jr., S. Leclercq,
Sr., C. Bauge, Jr., K. Boumediene, Sr., M. Demoor, Sr., P. Galera, Sr., Lab. of
Cellular microenvironnement and pathologies (MILPAT), Caen, France
Purpose: Chondrocyte is the major cell type of cartilage and it synthesizes
an abundant extracellular matrix (ECM) that contains two main speciﬁc
markers, type II collagen and aggrecan. Other characteristic markers are
also expressed in cartilage, but their expression is less abundant than those
observed for type II collagen and aggrecan. These ECM components are
more present in the territorial or interterritorial matrix and, presently, no
speciﬁc marker of human cartilage have been identiﬁed on the membrane
of articular chondrocytes.
Methods: Snorc mRNA expression was studied by Q-RT-PCR in chon-
drocytes and during chondrogenesis induction in adult mesenchymal stem
cells (AMSCs) from bone marrow. The protein alignment of Snorc was
made with Geneious and the 3D modelisation was performed with the
iTASSER server from the Michigan University.
Results: In this study, we have analyzed a new speciﬁc marker of the
differentiated status of human articular chondrocytes (HACs). Snorc is
a small transmembrane proteoglycan (PG) composed of 121 amino acids.
We reported that its expression decreased when HACs are dediffer-
entiated by sub-culturing or upon IL-1b treatment. Conversely, Snorc
expression is increased during the redifferentiation of HACs by BMP-2 in
a 3D culture model in hypoxia. Furthermore, when chondrogenesis was
induced in human AMSCs, the expression of this PG is greatly enhanced,
as observed for type II collagen, aggrecan and SOX9. In addition, Snorc
seemed to be expressed in a tissue-speciﬁc manner because no expres-
sion was detected in the skin, bone and AMSCs. Finally, the transcription
activity of the SNORC gene could be regulated, indirectly or directly, by
several transcriptions factors involved in the transactivation of type II
collagen gene, such as Sp1, SOX9 and/or HIF-1a, whose each of them
present a putative DNA binding site in the SNORC proximal promoter. The
primary structure of Snorc and the modelization of its quaternary
structure in 3D were analyzed to compare this PG spatial organization
between Mouse and Human species. This approach reveals that Snorc
seems to conserve the same spatial organization and contains one or
probably two transmembrane domains, an extracellular and an intracel-
lular domain.
Conclusions: During the HACs dedifferentiation, Snorc mRNA levels are
decreased whereas they are increased during the redifferentiation of HACs
or during the induction of chondrogenesis in AMSCs from bone marrow.
Thus, these results allow us to consider Snorc as a new speciﬁc marker of
the human articular cartilage that should be evaluated in order to better
appreciate the differentiation status of chondrocytes. Moreover, Snorc
could play an important role in cartilage homeostasis by potentially
inducing an intracellular signalisation pathway or perhaps participating to
the territorial matrix anchoring.
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GLUCOSAMINE AND AN ITS PEPTIDYL-DERIVATIVE INFLUENCE
TNF-ALPHA ACTIVATION OF NF-kB PATHWAY
L. Politi, D. Stoppoloni, R. Scandurra, A. Scotto d'Abusco. Univ. of Roma,
Roma, Italy
Purpose: NF-kB transcription factor regulates several cell signaling path-
ways, such as differentiation and inﬂammation, which are both altered in
osteoarthritis. IKKa and IKKb are kinases involved in the activation of the
NF-kB transcription factor. The aim of the present study was to determine
the effects of glucosamine (GlcN), which is administered in the treatmentof osteoarthritis, and of its 2-(N-Acetyl)-L-phenylalanylamido-2-deoxy-b-
D-glucose (NAPA) derivative, synthesized in our laboratory, on IKK kinases
and, consequently, on NF-kB activation in human chondrocytes.
Methods: The human chondrosarcoma cell line HTB-94 and human
primary chondrocytes were stimulated with TNFa after pre-treatment
with GlcN or NAPA. Gene mRNA expression level was evaluated by Real
Time-PCR. IkBa phosphorylation and p65 nuclear re-localization were
analyzed by Western blotting, IKKa nuclear translocalization was also
investigated by immunocytochemistry and Western blotting. IKK kinase
activity was studied by in vitro kinase assay.
Results: After TNFa stimulation, the mRNA expression level of some of the
genes under NF-kB control, such as IL-6 and IL-8, increased, while treat-
ment with GlcN and NAPA reverted the effect. We investigated the
possibility that GlcN and NAPA inhibit IKK kinase activity and found that
NAPA inhibits the IKKa kinase activity, whereas GlcN does not. Interest-
ingly, both GlcN and NAPA inhibit IKKa nuclear re-localization.
Conclusions: Our results demonstrate that glucosamine and its peptidyl-
derivative can interfere with NF-kB signaling pathway by inhibiting IKKa
activity in human chondrocytes. However, the mechanism of action of the
two molecules is not completely overlapping. While NAPA can both
speciﬁcally inhibit the IKKa kinase activity and IKKa nuclear trans-
localization, GlcN only acts on IKKa nuclear translocalization.
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INDUCTION OF HIGH TEMPERATURE REQUIREMENT A1, A SERINE
PROTEASE, BY TGF-BETA1 IN KNEE JOINTS OF MOUSE MODELS OF OA
Y. Li 1, I. Golshirazian 2, B.J. Asbury 2, J. Kim 2, L. Xu 1. 1Harvard Med. Sch.,
Boston, MA, USA; 2Harvard Sch. of Dental Med., Boston, MA, USA
Purpose: High temperature requirement A 1 (HTRA1), a serine protease,
has been implicated as a possible factor in the pathogenesis of osteoar-
thritis (OA) and rheumatoid arthritis (RA). In this study we examined the
effects of high temperature, tumor necrosis factors alpha (TNFa), trans-
forming growth factor beta 1 (TGF-b1), and a high hydrostatic pressure on
the induction of HTRA1 in chondrocytes.
Methods: Cell culture- Human primary chondrocytes were grown in the
medium supplemented with 10% FBS. Cells were then divided into
a control group or one of four experimental conditions: heating to 42oC,
addition of recombinant human TNFa (10ng/ml), addition of recombinant
human TGF-b1 (10ng/ml), or high hydrostatic pressure (5,000 psi ¼
34 MPa). Cells were then lysed with subsequent RNA extraction. Ex vivo
articular cartilage culture of mouse hip- Hip articular cartilage from six 10-
week old C57BL mice were pooled and homogenized with PT-DA 2112/EC
polytron at the lowest speed for 30 seconds. The sample was ﬁltered
through a 100 mmNylon Cell Strainer. The ﬁltered sample was re-dissolved
in 1ml of DMEM and divided into twowells. The samplewas cultured with
or without TGF-b1 (10ng/ml) for 6, 12 and 24 hrs at 37 oC. The cartilages
were then collected for isolation of total RNAs. Real-time PCR- cDNAs were
synthesized with total RNAs from the cultured human chondrocytes and
mouse hip cartilages. The level of HTRA1 in the samples was examined. A
cDNA sample in each experiment was tested in triplicate and each
experiment was performed twice. Immunohistology- The expression of
TGF-b1, p-Smad1 and p-Smad2 in Col11a1+/- mice at the age of 10 weeks
(a genetic form of mouse model of OA) and mice with surgical destabili-
zation of the medial meniscus (DMM, a non-genetic form of model of OA)
were examined (n¼4 in each experimental group). Parafﬁn sections were
incubated with polyclonal antibodies against TGF-b1, p-Smad1, and p-
Smad2. After overnight incubation at 4C, the sections were treated with
a biotinylated secondary antibody and peroxidase substrate. Staining with
isotype-matched normal IgG and staining without primary antibody were
also performed as negative controls. Intra-articular injection of a neutral-
izing TGF-b1 antibody into mice knee joints- The neutralizing TGF-b1
antibody (25 mg) or PBS as control was injected into the cavity of knee
joints of Col11a1+/- mice at the age of 10 weeks. An additional injection
was performed 2 weeks later. Knee joints were collected 2 weeks after the
second injection. Expression proﬁles of p-Smad2 and HtrA1 were exam-
ined by double immunohistostaining. Double immunohistostaining-
Sections from Col11a1+/- mice treated with the neutralizing TGF-b1
antibody, and DMM mice were incubated with primary polyclonal anti-
bodies against p-Smad2 and HtrA1 at 4C overnight. The sections were
